P2P on Postpartum Health
|
Meeting/ Workshop
|
AHRQ
|
OD/ DPCPSI/ ORWH, NICHD, NHLBI, NIMHD
|
|
|
P63, P13K and RAS oncogenes in tumorigenesis, immune deregulation and therapy of squamous cell carcinoma
|
Research Initiative
|
FDA
|
NIDCD
|
2014
|
|
Pain Assessments Web-Based Tool
|
Resource Development
|
CMS
|
CC, NCCIH, NINR, NIDCR, NIDA, NCI, NIA, NICHD, NIAMS, NIMH, NEI, NIGMS, NIDDK, NIAAA, NIMHD, NIBIB, NIDCD, NCATS, NHLBI, FIC
|
|
|
PALM007
|
Research Initiative
|
CDC
|
NIAID
|
2022
|
|
Pandemic Influenza Translational Research and novel universal countermeasure development
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Pandemic Response Team
|
Other
|
ASPR, CDC
|
NIAID
|
2020
|
|
PAR 22-049 'Integrating Biospecimen Science Approaches into Clinical Assay Development' Steering Committee Collaboration
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2020
|
|
Pathogen Detection Project and Interagency Collaboration on Genomics for Food and Feed Safety (Gen-FS)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
|
2015
|
|
Pathophysiological Actions of Anthrax Virulence Determinants
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Pathways to Prevention (P2P) Workshop Program
|
Meeting/ Workshop
|
AHRQ, CDC, ONC, OASH, ASPE, SAMHSA, HRSA, IHS
|
NCATS, NHLBI, NCI, NIMH, NIMHD, NICHD, NINDS, NIA, OD/ DPCPSI/ ORWH
|
2012
|
|
PCC Technical Working Group on PFAS
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ATSDR
|
|
|
|
PCORTF Frailty Functional Disabilities Project Working Group
|
Research Initiative
|
ASPE, AHRQ, CDC, CMS
|
|
2019
|
|
Pediatric COVID-19/MIS-C Interagency Team
|
Committee, Advisory Group, or Work Group
|
FDA, CDC, ASPR
|
NICHD, NHLBI, NIAID
|
2020
|
|
Pediatric Radiation Medical Countermeasures Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, FDA
|
NICHD
|
2022
|
|
Persistent Identifiers subgroup of the Subcommittee on Open Science of the National Science and Technology Council
|
Committee, Advisory Group, or Work Group
|
ACL
|
OD, OD/ DPCPSI/ ODSS
|
2022
|
|
Physiological Effects of Natural or Contaminating Compounds in a Rodent's Microenvironment
|
Research Initiative
|
FDA
|
NIEHS
|
|
|
Pilot Biosurveillance Working Group - National Biodefense Strategy
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ASPR
|
NIAID
|
2021
|
|
Population Assessment of Tobacco and Health (PATH) Study
|
Health Survey
|
FDA
|
NIDA
|
2011
|
|
Post-Traumatic Stress Disorder (PTSD)/Trauma Brain Injury (TBI), Suicide Prevention National Research Action Plan (NRAP) Workgroup
|
Committee, Advisory Group, or Work Group
|
OS
|
NIAAA, NIDA, NINDS
|
2012
|
|
Postdoctoral Fellowship in Genomic Science and Health Equity
|
Training Initiative
|
FDA
|
|
2021
|
|
PRAMS Interagency Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, NIH, CMS, HRSA
|
NICHD
|
|
|
Precision Oncology Interest Group (POIG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID, NHLBI, NIDDK, NIAMS, NCATS, NINDS, NIBIB, NICHD, NIDCR, OD
|
2021
|
|
Preclinical and Clinical Investigations of Severe Infection and Critical Illness - CDC Covid Response Team
|
Research Initiative
|
CDC
|
CC
|
2020
|
|
Preclinical and Clinical Investigations of Severe Infection and Critical Illness - CDC Covid Task Force
|
Research Initiative
|
CDC
|
CC
|
2020
|
|
Preclinical and Clinical Investigations of Severe Infection and Critical Illness - CDC Foundation
|
Research Initiative
|
CDC
|
CC
|
|
|
Preclinical Assessment of Phage Therapy for Pathogen Decolonization
|
Research Initiative
|
FDA
|
NIAID
|
2015
|
|
Predicting Drug Resistance with Machine Learning
|
Resource Development
|
ASPE
|
NIAID
|
2020
|
|
Pregnancy and Birth to 24 Months Project (P/B-24)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS
|
NCI, NHLBI, NICHD, NIDDK
|
2012
|
|
Pregnant People, Substance Use Disorder and Child Welfare, Sub Interagency Policy Committee (IPC) of the Maternal Health IPC
|
Committee, Advisory Group, or Work Group
|
ACF, ASPE, CDC, HRSA, IHS, SAMHSA, OS, IOS
|
NIDA, NICHD
|
2022
|
|
PregSource® Management Team
|
Public Education Campaign
|
CDC, HRSA
|
NCCIH, NHLBI, NICHD, NIEHS, NIMHD, NINR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH
|
2017
|
|
President's Advisory Council for HIV/AIDS (PACHA)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, HRSA, IHS, OASH
|
OD/ DPCPSI/ OAR
|
2016
|
|
President's Emergency Plan for AIDS Relief (PEPFAR) Cervical Cancer Prevention Expert Task Force
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2018
|
|
President's Emergency Plan for AIDS Relief (PEPFAR) Implementation Science/Combination Prevention
|
Research Initiative
|
CDC
|
FIC, NCI, NIAAA, NIAID, NIDA, NIMH, OD/ DPCPSI/ OAR
|
2005
|
|
President's Task Force on Environmental Health Risks and Safety Risks to Children (PTFCEH)
|
Committee, Advisory Group, or Work Group
|
ACF, ASPR, CDC, ATSDR, FDA, OASH, SAMHSA
|
NICHD, NHLBI, NIMH, NIMHD
|
|
|
President's Task Force on Environmental Health Risks and Safety Risks to Children: Lead Exposures Subcommittee
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, HRSA, OS
|
NHLBI, NICHD, NIEHS
|
|
|
President’s Task Force (PTF) on Environmental Health Risks and Safety Risks to Children: Chemical Exposures (ChEx) Subcommittee
|
Committee, Advisory Group, or Work Group
|
FDA, OASH
|
NIEHS
|
1997
|
|
Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB)
|
Committee, Advisory Group, or Work Group
|
ASPR
|
NIAID
|
2015
|
|
Prevention Research Coordinating Committee (PRCC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, OS, FDA, OASH
|
CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ OAR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ ODS, OD/ OLPA
|
1997
|
|
Probiotic and Prebiotic Working Group [PPWG] (PPWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCCIH, NIAMS, NIDA, NIDCR, OD/ DPCPSI/ ODS, CC, CIT, CSR, FIC, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ OEDI
|
2006
|
|
Production and purification of biological compounds
|
Research Initiative
|
FDA
|
NIDDK
|
|
|
Public Health and Emergency Medical Countermeasures Enterprise (PHEMCE)
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, OS, SAMHSA
|
NIAID, NIAMS, NICHD, NINDS, NLM
|
2007
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Preparedness Against Chemical Threats (PACT) Working Group (PHEMCE PACT Working Group)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, NINDS
|
2007
|
|
Public Health Service Technology Transfer Policy Board (TTPB)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
OD/ OIR/ OTT, OD/ OSP, OD/ OIR, OD/ OER
|
1994
|
|
|